🖼
Figure 6 — Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyel
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-paper-40988129-6
Figure 6Figure 6
Proposed diagnostic flow chart for differentiating MOGAD, NMOSD and MS based on CSF biomarkers. Flow diagram illustrating a proposed decision pathway for the differential diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) in patients presenting with acute clinical worsening and MRI evidence of new lesion formation. Initial separation is based on CSF levels of granulocyte activation markers (GAM) and complement factors C5/C5a. If elevated, differentiation between MOGAD and NMOSD is guided by astrocytic damage markers GFAP and S100B. Absence of biomarker increases suggests a diagnosis of MS.
▸Metadata
| pmid | paper-40988129 |
| caption | Proposed diagnostic flow chart for differentiating MOGAD, NMOSD and MS based on CSF biomarkers. Flow diagram illustrating a proposed decision pathway for the differential diagnosis of myelin oligoden |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC13058455/bin/awaf345f6.jpg |
| paper_title | Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis. |
| figure_label | Figure 6 |
| figure_number | 6 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.